Clinical Trials in Boston

Showing 8361-8380 of 17,836 trials

A Text Messaging (SMS) Intervention to Improve Adherence to Stimulant Medication in Adults With ADHD in the Primary Care Setting

NCT04189575

This study will assess the efficacy of the text messaging (SMS-based) disease management intervention to improve adherence to stimulants in adults with Attention Deficit/Hyperactivity Disorder (ADHD) within the Partners primary and psychiatry care settings. Participants in the study will receive customized text messages twice a day, every day, for a duration of 9 months. The text messages will include reminders to adhere to the individualized medication regimen, reminders to call their clinician for a prescription refill followed by reminders to pick up medication from the pharmacy, and educational reminders about ADHD and its treatment

Attention Deficit/Hyperactivity Disorder

Massachusetts General Hospital117 participantsStarted May 2018

Boston, Massachusetts, United States

UNKNOWNNA< 1 mile

Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response

NCT03153488

This is a 6-month trial in adults to find out if certain neuromarkers can predict individual treatment response to stimulant medications for Attention Deficit Hyperactivity Disorder (ADHD). Males and females, ages 18-45, will complete an MRI scan at MIT prior to beginning medication for ADHD as determined by a treating clinician outside the context of this study.

Attention Deficit Hyperactivity Disorder

Massachusetts General Hospital60 participantsStarted Jul 2018

Boston, Massachusetts, United States

COMPLETEDPhase 1/2< 1 mile

Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

NCT02024087

The purpose of this study is to evaluate the safety and tolerability of dalantercept plus sorafenib in patients with advanced hepatocellular carcinoma (HCC) to determine the recommended dose level of dalantercept in combination with sorafenib.

Advanced Adult Hepatocellular Carcinoma

Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA21 participantsStarted Aug 2014

Chicago, Illinois, United States • Westwood, Kansas, United States • Boston, Massachusetts, United States +4 more locations

A Text Messaging (SMS) Intervention to Improve Adherence to Stimulant Medication in Adults With ADHD in the Primary Care Setting

Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response

Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Find Trials by Condition in Boston

Natural History Study in Huntington Disease Gene Expansion Carriers (HDGECs) - SHIELD HD

Study of AZD5991 Alone or in Combination With Venetoclax in Relapsed or Refractory Haematologic Malignancies.

Study of Denosumab in Subjects With Giant Cell Tumor of Bone

Acceptability of Telehealth Triage Using Robotic Systems in COVID-19

A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma

KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC

Open Label Study of Long Term Evaluation Against LDL-C Trial

A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.

Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma

Comparison of VT Ablation Outcomes Using Remote MAGNETIC Navigation Versus Manual Approach in a Low LVEF Population

An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma

Study of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary Nailing

Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients

Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))

Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)